# Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation

> **NCT01660321** · PHASE4 · COMPLETED · sponsor: **ParaPRO LLC** · enrollment: 26 (actual)

## Conditions studied

- Pediculosis

## Interventions

- **DRUG:** spinosad

## Key facts

- **NCT ID:** NCT01660321
- **Lead sponsor:** ParaPRO LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-10
- **Final completion:** 2012-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2012-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01660321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01660321, "Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01660321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*